These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25948176)

  • 61. [Bone Marrow Osteoblasts Promotes the Proliferation Leukemia Stem Cell by Up-regulating Interleukin-1].
    Cao ZJ; Li YS; Wang HJ; Xue ZY; Chen SY; Tang KJ; Wang M; Rao Q
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1348-1353. PubMed ID: 36208234
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Loss of FGFR3 Delays Acute Myeloid Leukemogenesis by Programming Weakly Pathogenic CD117-Positive Leukemia Stem-Like Cells.
    Guo C; Ran Q; Sun C; Zhou T; Yang X; Zhang J; Pang S; Xiao Y
    Front Pharmacol; 2020; 11():632809. PubMed ID: 33584313
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Loss of IRF7 accelerates acute myeloid leukemia progression and induces VCAM1-VLA-4 mediated intracerebral invasion.
    Wang H; Zhang D; Cui X; Dai Y; Wang C; Feng W; Lv X; Li Y; Wang L; Ru Y; Zhang Y; Ren Q; Zheng G
    Oncogene; 2022 Apr; 41(16):2303-2314. PubMed ID: 35256780
    [TBL] [Abstract][Full Text] [Related]  

  • 64. GAS2-Calpain2 axis contributes to the growth of leukemic cells.
    Sun L; Zhou H; Liu H; Ge Y; Zhang X; Ma W; Wu D; Zhao Y
    Acta Biochim Biophys Sin (Shanghai); 2015 Oct; 47(10):795-804. PubMed ID: 26358320
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Reduction of leukemic burden via bone-targeted nanoparticle delivery of an inhibitor of C-chemokine (C-C motif) ligand 3 (CCL3) signaling.
    Ackun-Farmmer MA; Soto CA; Lesch ML; Byun D; Yang L; Calvi LM; Benoit DSW; Frisch BJ
    FASEB J; 2021 Apr; 35(4):e21402. PubMed ID: 33724567
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Preclinical evaluation of the ROCK1 inhibitor, GSK269962A, in acute myeloid leukemia.
    Pan T; Wang S; Feng H; Xu J; Zhang M; Yao Y; Xu K; Niu M
    Front Pharmacol; 2022; 13():1064470. PubMed ID: 36561342
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Reseach Progress of Ki-67 in Acute Myeloid Leukemia-Review].
    Wang M; Wang LR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1264-8. PubMed ID: 27531813
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Macrophage inflammatory protein (mip)-1-alpha stem-cell inhibitor (sci) does not affect clonal growth of human solid tumor-cell lines in-vitro.
    Korfel A; Vonmarschall Z; Koenigsmann M; Oberberg D; Reufi B; Thiel E; Berdel W
    Int J Oncol; 1994 Feb; 4(2):353-7. PubMed ID: 21566931
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The progress of early growth response factor 1 and leukemia.
    Tian J; Li Z; Han Y; Jiang T; Song X; Jiang G
    Intractable Rare Dis Res; 2016 May; 5(2):76-82. PubMed ID: 27195189
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Alarmins released during local antitumor treatments play an essential role in enhancing tumor growth inhibition at treated and non-treated sites via a derivative of CCL3.
    Kanegasaki S; Tsuchiya T
    Oncoimmunology; 2014 Nov; 3(10):e958956. PubMed ID: 25941584
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lentzsch S, Gries M, Janz M, Bargou R, Dörken B, Mapara MY. Macrophage inflammatory protein 1-alpha (MIP-1α) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells. Blood. 2003;101(9):3568-3573.
    Blood; 2023 Jan; 141(4):437. PubMed ID: 36701165
    [No Abstract]   [Full Text] [Related]  

  • 72. Standardized assays to monitor drug sensitivity in hematologic cancers.
    Ayuda-Durán P; Hermansen JU; Giliberto M; Yin Y; Hanes R; Gordon S; Kuusanmäki H; Brodersen AM; Andersen AN; Taskén K; Wennerberg K; Enserink JM; Skånland SS
    Cell Death Discov; 2023 Dec; 9(1):435. PubMed ID: 38040674
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Trends and outcomes in allogeneic hematopoietic stem cell transplant for multiple myeloma at Mayo Clinic.
    Mir MA; Kapoor P; Kumar S; Pandey S; Dispenzieri A; Lacy MQ; Dingli D; Hogan W; Buadi F; Hayman S; Gandhi M; Gertz MA
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):349-357.e2. PubMed ID: 25958193
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways.
    Bakhtiyari M; Liaghat M; Aziziyan F; Shapourian H; Yahyazadeh S; Alipour M; Shahveh S; Maleki-Sheikhabadi F; Halimi H; Forghaniesfidvajani R; Zalpoor H; Nabi-Afjadi M; Pornour M
    Cell Commun Signal; 2023 Sep; 21(1):252. PubMed ID: 37735675
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Macrophage inflammatory protein-1α promotes the growth of acute myeloid leukemia cells].
    Lu P; Wang YJ; Zheng YW; Dong F; Pang YK; Cheng H; Yuan WP; Cheng T; Hao S
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):306-11. PubMed ID: 25948176
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Expressions of MIP-1alpha, MCP-1 and their receptors CCR-1, CCR-2 in chronic myeloid leukemia cells].
    Wang WL; Shen T; Hui YR; Gu XC; Li RS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):433-6. PubMed ID: 16800914
    [TBL] [Abstract][Full Text] [Related]  

  • 77. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells.
    Oba Y; Lee JW; Ehrlich LA; Chung HY; Jelinek DF; Callander NS; Horuk R; Choi SJ; Roodman GD
    Exp Hematol; 2005 Mar; 33(3):272-8. PubMed ID: 15730850
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Abl protein kinase abrogates the response of multipotent haemopoietic cells to the growth inhibitor macrophage inflammatory protein-1 alpha.
    Wark G; Heyworth CM; Spooncer E; Czaplewski L; Francis JM; Dexter TM; Whetton AD
    Oncogene; 1998 Mar; 16(10):1319-24. PubMed ID: 9546433
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Significance of macrophage inflammatory protein-1 alpha (MIP-1alpha) in multiple myeloma.
    Terpos E; Politou M; Viniou N; Rahemtulla A
    Leuk Lymphoma; 2005 Dec; 46(12):1699-707. PubMed ID: 16263571
    [TBL] [Abstract][Full Text] [Related]  

  • 80. MIP-1 alpha and myeloma bone disease.
    Roodman GD; Choi SJ
    Cancer Treat Res; 2004; 118():83-100. PubMed ID: 15043189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.